Monitor for future takedowns from the shelf, which could lead to near-term dilution. Since this is a resale registration, the company does not receive proceeds, but increased share float may affect trading dynamics. Watch for insider selling patterns in upcoming Form 4 filings.
Price Chart
Executive Summary
Opus Genetics' S-3 shelf registration has become effective, allowing the company to sell or issue up to 7,374,632 shares of common stock from time to time. The shelf relates to resale of shares by existing stockholders and does not raise new capital for the company.
Key Facts
- S-3 shelf registration (File No. 333-294295) became effective on April 22, 2026
- Registration covers resale of 7,374,632 shares of common stock by selling stockholders
- Shares are issuable upon conversion of Series B Preferred Stock from a prior $25 million private placement
- No new capital is raised by this registration; it satisfies contractual resale obligations
Financial Impact
Up to 7,374,632 shares may be sold over time, representing potential dilution if sold in the open market. No immediate cash inflow to the company.
Risk Factors
- Potential share price pressure if large volumes are sold under the shelf
- Increased stock volatility if selling stockholders liquidate positions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001295 |
| Document: 9999999995-26-001295-index.html | 9999999995-26-001295 |
| Document: 9999999995-26-001295.txt | 9999999995-26-001295 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 144 | $3.52 | awaiting T+60 | — | $3.32 (−5.68%) |
Oct 21, 2026 5d ago | 8-K | $3.82 | awaiting T+60 | — | $3.32 (−13.09%) |
Oct 15, 2026 11d ago | 8-K | $3.84 | awaiting T+60 | — | $3.32 (−13.54%) |
Oct 15, 2026 11d ago | Press Release | $3.84 | awaiting T+60 | — | $3.32 (−13.54%) |
Sep 22, 2026 4w ago | Institutional Cluster | $5.16 | awaiting T+60 | — | $3.32 (−35.66%) |
Sep 11, 2026 6w ago | 8-K | $6.04 | awaiting T+60 | — | $3.32 (−45.03%) |
Sep 9, 2026 6w ago | 8-K | $5.73 | awaiting T+60 | — | $3.32 (−42.06%) |
Sep 2, 2026 7w ago | Press Release | $4.45 | awaiting T+60 | — | $3.32 (−25.39%) |
Aug 6, 2026 11w ago | 8-K | $3.72 | awaiting T+60 | — | $3.32 (−10.75%) |
Jul 23, 2026 13w ago | 144 | $2.92 $4.05 | ▲ +38.70% | ▲ +34.15% | $3.32 (+13.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers